X4 Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.79
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.26
|
0.04
|
13.33%
|
|
2022-06-30
|
-0.64
|
-0.60
|
0.04
|
6.25%
|
|
2022-03-31
|
-0.61
|
-0.72
|
-0.11
|
-18.03%
|
|
2021-12-31
|
-0.68
|
-1.24
|
-0.56
|
-82.35%
|
|
2021-09-30
|
-0.72
|
-0.76
|
-0.04
|
-5.56%
|
|
2021-06-30
|
-0.74
|
-0.74
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.86
|
-1.30
|
-0.44
|
-51.16%
|
|
2020-12-31
|
-0.90
|
-0.91
|
-0.01
|
-1.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.58
|
|
2021-12-31
|
-4.04
|
|
2020-12-31
|
-3.10
|
|
2019-12-31
|
-9.57
|
|
2018-12-31
|
-18.02
|
|
2017-12-31
|
-35.47
|